Literature DB >> 19182165

Determination of basal metabolic rate and body composition with bioelectrical impedance method in children with cerebral palsy.

Cemil Sert1, Ozlem Altindağ, Fatma Sirmatel.   

Abstract

This study uses the bioelectrical impedance method to assess the body composition, basal metabolic rate, and some other physical properties of children with cerebral palsy. In this study, 41 children with spastic cerebral palsy were assessed, and 56 normally developed children were included as control. Parameters such as body compositions, basal metabolic rate, body resistance, liquid compartment, and capacitance of patients and control group were measured and analyzed statistically. Basal metabolic rate, body mass index, extracellular liquid, intracellular liquid, body capacitance, and resistance differed significantly compared to the control group (P < .01), whereas extracellular mass, lean body mass, body cell mass, and fat mass did not differ significantly compared to the control group (P > .05). Parameters such as basal metabolic rate, body composition, and body resistance can be determined using the bioelectrical impedance method in children with cerebral palsy.

Entities:  

Mesh:

Year:  2009        PMID: 19182165     DOI: 10.1177/0883073808323024

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  3 in total

1.  Resting metabolic rate and its adjustments as predictors of risk protein-energy wasting in hemodialysis patients.

Authors:  Jingjing Da; Yanjun Long; Qian Li; Xia Yang; Jing Yuan; Yan Zha
Journal:  Biosci Rep       Date:  2021-04-30       Impact factor: 3.840

2.  [Anthropometric evaluation of pediatric patients with non-progressive chronic encephalopathy according to different methods of classification].

Authors:  Jéssica Socas Teixeira; Mirian Martins Gomes
Journal:  Rev Paul Pediatr       Date:  2014-10-03

3.  Sasang constitutional medicine as a holistic tailored medicine.

Authors:  Jong Yeol Kim; Duong Duc Pham
Journal:  Evid Based Complement Alternat Med       Date:  2009-09       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.